• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Roche pushes back Spark takeover again as regulatory review drags on

Share:

May 20, 2019

Swiss drugmaker Roche is pushing back its $4.3 billion takeover offer for gene therapy specialist Spark Therapeutics for a third time in recent months, this time until June 14, as a U.S. regulatory review of the deal drags on.

Roche and Spark are now due to refile their premerger notification on May 23, “in order to provide the government with additional time,” the companies said in a joint statement on Tuesday. “The regulatory review of the transaction is ongoing, and the parties are actively working with the government to facilitate that process.”

Roche has said the Federal Trade Commission needed even more time to complete its review.

Date: May 20, 2019

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Yahoo Finance

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Aveo Oncology Stock Spikes on Rumors of AstraZeneca AcquisitionAveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition
  • Predictive Oncology Completes Acquisition of Quantitative MedicineAcquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and DevelopmentPredictive Oncology Completes Acquisition of Quantitative MedicineAcquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and Development
  • EyeCare Partners Completes Acquisition of Associated Retinal ConsultantsEyeCare Partners Completes Acquisition of Associated Retinal Consultants
  • Is Your Community Ready For A Connected Community of Care Model?Is Your Community Ready For A Connected Community of Care Model?
  • CooperSurgical® Acquires AEGEA MedicalCooperSurgical® Acquires AEGEA Medical
  • Ontrak Acquires Science-Backed, Behavior Change Platform LifeDojo, IncOntrak Acquires Science-Backed, Behavior Change Platform LifeDojo, Inc
  • Afya Limited Announces the Acquisition of UniRedentor – Sociedade Universitária RedentorAfya Limited Announces the Acquisition of UniRedentor – Sociedade Universitária Redentor
  • Cognizant to Integrate TriZetto with Microsoft Cloud for HealthcareCognizant to Integrate TriZetto with Microsoft Cloud for Healthcare

Trending This Week

  • Denials Management Named Most Time-Consuming Task in RCM
  • Why Adopting Value-Based Care Models for Autism Care Is Imperative
  • Why AI-Driven Cancer Screening Will Soon Become Standard of Care
  • Bioventus Completes Divestiture of its Wound Business
  • Enzo Biochem Reports Significant Progress Toward Completing the Clinical Lab Asset Sale
  • eMolecules Acquires Specs Compound Handling B.V.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications